Literature DB >> 4228454

Down's syndrome at young maternal age; cytogenetical and genealogical study of eighty-two families.

M Mikkelson.   

Abstract

Mesh:

Year:  1967        PMID: 4228454

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


× No keyword cloud information.
  8 in total

1.  Human karyotype polymorphism. III. Routine ank fluorescence microscopic investigation of chromosomes in normal adults and mentally retarded children.

Authors:  A V Mikelsaar; M E Käosaar; S J Tüür; M H Viikmaa; T A Talvik; J Lääts
Journal:  Humangenetik       Date:  1975

2.  Down's syndrome in Western Australia: cytogenetics and incidence.

Authors:  M T Mulcahy
Journal:  Hum Genet       Date:  1979-04-17       Impact factor: 4.132

3.  Quantitative studies on the arrangement of human metaphase chromosomes. IV. The association frequency of human acrocentric marker chromosomes.

Authors:  H Zankl; K D Zang
Journal:  Humangenetik       Date:  1974

Review 4.  Down's syndrome. Current stage of cytogenetic research.

Authors:  M Mikkelsen
Journal:  Humangenetik       Date:  1971

5.  Parental dermotoglyphs in age-independent mongolism.

Authors:  J H Priest
Journal:  J Med Genet       Date:  1969-09       Impact factor: 6.318

6.  A prospective, cytogenetic study of recurrent abortion.

Authors:  J A Wilson
Journal:  J Med Genet       Date:  1969-03       Impact factor: 6.318

7.  Risk of chromosomal abnormalities, with emphasis on live-born offspring of young mothers.

Authors:  B B Little; S M Ramin; B S Cambridge; N R Schneider; D S Cohen; L M Snell; M J Harrod; W L Johnston
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

8.  Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.

Authors:  Maral Adel Fahmideh; Giorgio Tettamanti; Catharina Lavebratt; Mats Talbäck; Tiit Mathiesen; Birgitta Lannering; Kimberly J Johnson; Maria Feychting
Journal:  Clin Epidemiol       Date:  2018-06-20       Impact factor: 4.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.